162 related articles for article (PubMed ID: 18628433)
21. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.
Schwartz SM; Daling JR; Doody DR; Wipf GC; Carter JJ; Madeleine MM; Mao EJ; Fitzgibbons ED; Huang S; Beckmann AM; McDougall JK; Galloway DA
J Natl Cancer Inst; 1998 Nov; 90(21):1626-36. PubMed ID: 9811312
[TBL] [Abstract][Full Text] [Related]
22. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
Madeleine MM; Anttila T; Schwartz SM; Saikku P; Leinonen M; Carter JJ; Wurscher M; Johnson LG; Galloway DA; Daling JR
Int J Cancer; 2007 Feb; 120(3):650-5. PubMed ID: 17096345
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of human papillomavirus DNA in vulvar carcinoma.
Monk BJ; Burger RA; Lin F; Parham G; Vasilev SA; Wilczynski SP
Obstet Gynecol; 1995 May; 85(5 Pt 1):709-15. PubMed ID: 7724101
[TBL] [Abstract][Full Text] [Related]
24. HPV detection and genotyping in vulvar squamous cell carcinoma in northern Thailand.
Siriaunkgul S; Settakorn J; Sukpan K; Srisomboon J; Utaipat U; Lekawanvijit S; Khunamornpong S
Asian Pac J Cancer Prev; 2014; 15(8):3773-8. PubMed ID: 24870792
[TBL] [Abstract][Full Text] [Related]
25. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
[TBL] [Abstract][Full Text] [Related]
26. Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk.
Jang JH; Cotterchio M; Borgida A; Liu G; Gallinger S; Cleary SP
Mol Carcinog; 2013 Nov; 52 Suppl 1(0 1):E103-9. PubMed ID: 23908141
[TBL] [Abstract][Full Text] [Related]
27. CCR5 genetic variants and epidemiological determinants for HPV infection and cervical premalignant lesions.
Mangieri LFL; Sena MM; Cezar-Dos-Santos F; Trugilo KP; Okuyama NCM; Pereira ÉR; Maria GCQ; Watanabe MAE; de Oliveira KB
Int J Immunogenet; 2019 Oct; 46(5):331-338. PubMed ID: 31183980
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
Smith JS; Backes DM; Hoots BE; Kurman RJ; Pimenta JM
Obstet Gynecol; 2009 Apr; 113(4):917-924. PubMed ID: 19305339
[TBL] [Abstract][Full Text] [Related]
29. IL2RA rs2104286 and IL2 rs2069762 polymorphisms may be associated with bipolar disorder and its clinical findings.
Pehlivan S; Aytac HM; Nursal AF; Tuncel FC; Pehlivan M
Nucleosides Nucleotides Nucleic Acids; 2024; 43(5):441-452. PubMed ID: 37843874
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
Mpunga T; Chantal Umulisa M; Tenet V; Rugwizangoga B; Milner DA; Munyanshongore C; Heideman DAM; Bleeker MCG; Tommasino M; Franceschi S; Baussano I; Gheit T; Sayinzoga F; Clifford GM
Int J Cancer; 2020 Mar; 146(6):1514-1522. PubMed ID: 31173641
[TBL] [Abstract][Full Text] [Related]
31. PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy.
Chinn Z; Stoler MH; Mills AM
Histopathology; 2019 Jan; 74(2):256-268. PubMed ID: 30067880
[TBL] [Abstract][Full Text] [Related]
32. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK
Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794
[TBL] [Abstract][Full Text] [Related]
33. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.
Chaturvedi AK; Kleinerman RA; Hildesheim A; Gilbert ES; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fossa SD; Joensuu H; Travis LB; Engels EA
J Clin Oncol; 2009 Feb; 27(6):967-73. PubMed ID: 19114696
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.
Insinga RP; Liaw KL; Johnson LG; Madeleine MM
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1611-22. PubMed ID: 18628412
[TBL] [Abstract][Full Text] [Related]
35. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
Song N; Tan W; Xing D; Lin D
Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
[TBL] [Abstract][Full Text] [Related]
36. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas.
Huang FY; Kwok YK; Lau ET; Tang MH; Ng TY; Ngan HY
Cancer Genet Cytogenet; 2005 Feb; 157(1):42-8. PubMed ID: 15676146
[TBL] [Abstract][Full Text] [Related]
37. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva.
de Sanjosé S; Alemany L; Ordi J; Tous S; Alejo M; Bigby SM; Joura EA; Maldonado P; Laco J; Bravo IG; Vidal A; Guimerà N; Cross P; Wain GV; Petry KU; Mariani L; Bergeron C; Mandys V; Sica AR; Félix A; Usubutun A; Seoud M; Hernández-Suárez G; Nowakowski AM; Wilson G; Dalstein V; Hampl M; Kasamatsu ES; Lombardi LE; Tinoco L; Alvarado-Cabrero I; Perrotta M; Bhatla N; Agorastos T; Lynch CF; Goodman MT; Shin HR; Viarheichyk H; Jach R; Cruz MO; Velasco J; Molina C; Bornstein J; Ferrera A; Domingo EJ; Chou CY; Banjo AF; Castellsagué X; Pawlita M; Lloveras B; Quint WG; Muñoz N; Bosch FX;
Eur J Cancer; 2013 Nov; 49(16):3450-61. PubMed ID: 23886586
[TBL] [Abstract][Full Text] [Related]
38. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus and invasive cervical cancer in Brazil.
Eluf-Neto J; Booth M; Muñoz N; Bosch FX; Meijer CJ; Walboomers JM
Br J Cancer; 1994 Jan; 69(1):114-9. PubMed ID: 8286192
[TBL] [Abstract][Full Text] [Related]
40. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
Kashofer K; Regauer S
Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
